The ESG Evolution Moves Into 2022

Mirova’s Amber Fairbanks talks opportunities, risks, and regulations for environmental, social, and governance investing.

As a panelist at Natixis Investment Managers’ Institutional Investor Outlook 2022 event, Mirova Sustainable Global Equities Portfolio Manager Amber Fairbanks offered insights on Environmental, Social and Governance investing for 2022 and beyond. Topics addressed include:

  • Exciting innovation trends and investment opportunities in healthcare, along with wind energy and green hydrogen
  • Ongoing risk management consideration of companies’ brand image regarding ESG policies and practices
  • Increasing standardization of quantitative data together with the critical qualitative evaluation of portfolio companies’ ESG activities
  • Mirova’s approach to exploiting market inefficiencies to drive outperformance and create a portfolio with positive social and environmental impact
Sustainable investing focuses on investments in companies that relate to certain sustainable development themes and demonstrate adherence to environmental, social and governance (ESG) practices; therefore the universe of investments may be limited and investors may not be able to take advantage of the same opportunities or market trends as investors that do not use such criteria. This could have a negative impact on an investor’s overall performance depending on whether such investments are in or out of favor.

Not all affiliated investment managers integrate ESG considerations into decision-making to the same extent. Investors should always review the offering documents on im.natixis.com before investing in any fund or strategy to fully understand the methods and extent an investment manager incorporates ESG factors into their investment and voting decisions.

The views and opinions expressed may change based on market and other conditions. This material is provided for informational purposes only and should not be construed as investment advice. There can be no assurance that developments will transpire as forecasted. Actual results may vary.

Mirova is operated in the US through Mirova US LLC.

4270762.1.1